Canton Strategic Holdings (CNTN) Operating Income (2021 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Operating Income came in at -$36.9 million in Q1 2026, down 1347.71% YoY from $3.0 million in Q1 2025, and down 170.8% on a QoQ basis from -$13.6 million in Q4 2025.
Canton Strategic Holdings (CNTN) Operating Income (2021 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 6 years of Operating Income data on file, last reported at -$36.9 million in Q1 2026.
- Quarterly Operating Income fell 1347.71% year-over-year to -$36.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$54.4 million (down 331.99% YoY) and the FY2025 annual result came in at -$20.1 million, down 62.15% from the prior year.
- Operating Income eased to -$36.9 million in Q1 2026, from -$13.6 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$1.4 million in Q1 2022 to a low of -$36.9 million in Q1 2026.
- A 5-year average of -$5.0 million and a median of -$2.4 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income slumped 1638.74% — and 2025, when it jumped 45.84%.
- Tracing CNTN's Operating Income over 5 years: stood at -$1.8 million in 2022, then plunged by 43.29% to -$2.5 million in 2023, then slumped by 50.67% to -$3.8 million in 2024, then sank by 257.0% to -$13.6 million in 2025, then slumped by 170.8% to -$36.9 million in 2026.
- The last three Operating Income figures came in at -$36.9 million (Q1 2026), -$13.6 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Canton Strategic Holdings | 419.57 Mn | 419.57 Mn | - | -36.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.87 Mn |
| Dec 31, 2025 | -13.61 Mn |
| Sep 30, 2025 | -2.09 Mn |
| Jun 30, 2025 | -1.85 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Dec 31, 2024 | -3.81 Mn |
| Sep 30, 2024 | -3.87 Mn |
| Jun 30, 2024 | -2.37 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | -2.53 Mn |
| Sep 30, 2023 | -1.85 Mn |
| Jun 30, 2023 | -2.36 Mn |
| Mar 31, 2023 | -2.71 Mn |
| Dec 31, 2022 | -1.77 Mn |
| Sep 30, 2022 | -2.13 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Mar 31, 2022 | -1.35 Mn |
| Dec 31, 2021 | -101,593.00 |
| Sep 30, 2021 | -541,113.00 |
| Jun 30, 2021 | -1.10 Mn |